Implementation of CBT-I in Cancer Clinics
Implementation of a Stepped Care Cognitive-Behavioral Therapy for Insomnia in Routine Cancer Care
1 other identifier
interventional
120
1 country
1
Brief Summary
Insomnia affects 30-60% of cancer patients, thus making it one of the most common disturbances in this population. When untreated, which is the rule rather than the exception, insomnia often becomes chronic. Chronic insomnia is associated with numerous negative consequences (e.g., increased risk for psychological disorders, health care costs). A large body of evidence supports the efficacy of cognitive-behavioral therapy for insomnia (CBT-I) in cancer patients, but CBT-I is still not offered routinely in cancer clinics. Self-administered CBT-I (e.g., video-based intervention) has been developed to increase patients' access to this treatment. However, results of clinical trials have suggested that these minimal treatments would be better used as a first step of a stepped care model. In stepped care, patients receive only the level of intervention they need. Generally, the entry level is a minimal, less costly, intervention (e.g., self-help intervention) followed by a more intensive form of treatment if needed (if the patient is still symptomatic). The investigators have recently assessed the efficacy of a stepped care model to administer CBT-I in cancer patients, which includes a web-based CBT-I (called Insomnet) followed by up to 3 sessions with a psychotherapist if the patient is still symptomatic. Results of this study suggest that this model of care is non-inferior to a standard face-to-face treatment (Savard, Ivers, et al., in revision), while being more cost-effective. A stepped care CBT-I could therefore be offered in routine cancer care clinics. This project will assess the feasibility and effectiveness of implementing a stepped care CBT-I in real-world cancer clinics, using a non-randomized stepped wedge design to compare the effects of our program (active phase) with a passive phase. The program is called Insomnia in Patients with Cancer - Personalized Treatment (IMPACT). The stepped care CBT-I (active intervention) is being implemented sequentially in the four participating hospitals over a number of equally spaced time periods of 4 months (wedges), for a total of 5 time points, over a period of 20 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 13, 2019
CompletedFirst Submitted
Initial submission to the registry
March 18, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedSeptember 19, 2024
September 1, 2024
5.5 years
March 18, 2021
September 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Implementation (organizational) measures
Referral, enrolment and completion rates to the stepped care CBT-I in each clinical setting.
Passive phase (4 months) vs. active phase (20 months), through study completion, an average of 24 months
1) Change in Insomnia Severity Index Scores
Change in Insomnia Severity Index Scores from pre- to post-intervention. The ISI is a 7-item questionnaire designed to evaluate insomnia severity. A score greater than or equal to 8 indicates the presence of insomnia symptoms.
Pre-treatment and post-treatment (6-8 weeks later)
2) Change in sleep efficiency (SE)
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep efficiency (SE) index (%) = Total sleep time/total time spent in bed X 100.
Pre-treatment and post-treatment (6-8 weeks later)
3) Change in sleep onset latency (SOL)
Change in daily sleep diary parameters from pre- to post-intervention: Change in sleep onset latency (SOL) = Time to sleep after lights out.
Pre-treatment and post-treatment (6-8 weeks later)
4) Change in wake after sleep onset (WASO)
Change in daily sleep diary parameters from pre- to post-intervention: Change in wake after sleep onset (WASO) = Summation of nocturnal awakenings.
Pre-treatment and post-treatment (6-8 weeks later)
5) Change in total wake time (TWT)
Change in daily sleep diary parameters from pre- to post-intervention: Change in total wake time (TWT) = Summation of SOL, WASO, and early morning awakening.
Pre-treatment and post-treatment (6-8 weeks later)
6) Change in total sleep time (TST)
Change in daily sleep diary parameters from pre- to post-intervention: Change in total sleep time (TST) = Time in bed minus total wake time.
Pre-treatment and post-treatment (6-8 weeks later)
7) Hospital Anxiety and Depression Scale (HADS)
Change scores from pre to post-intervention: Hospital Anxiety and Depression Scale (HADS): A 14-item questionnaire comprising 7 items assessing depression and 7 items assessing anxiety. Scores obtained for each subscale range from 0 to 21.
Pre-treatment and post-treatment (6-8 weeks later)
8) Fatigue Symptom Inventory (FSI)
Change scores from pre to post-intervention: Fatigue Symptom Inventory (FSI): A 14-item questionnaire measuring perceived fatigue. Each item is rated on an 11-point Likert scale, ranging from 0 to 10. A higher score indicates a higher level of fatigue or interference or a longer duration of fatigue.
Pre-treatment and post-treatment (6-8 weeks later)
9) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Change scores from pre to post-intervention: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): A 30-item questionnaire. Scores are transformed to give a score ranging from 0 to 100.
Pre-treatment and post-treatment (6-8 weeks later)
10) Satisfaction with Life Scale (SWLS)
Change scores from pre to post-intervention: Satisfaction with Life Scale (SWLS): A 5-item questionnaire (Likert scale from 1 to 7) designed to measure global cognitive judgments of satisfaction with one's life.
Pre-treatment and post-treatment (6-8 weeks later)
1) Psychologists' adherence to the protocol
Psychologists' self-assessed adherence to the CBT-I protocol (%)
Throughout the active phase, up to 20 months
2) Psychologists' perceived self-efficiency
Psychologists' perceived self-efficiency in using CBT-I protocol (%)
Throughout the active phase, up to 20 months
Secondary Outcomes (8)
1) Demographic characteristics
Pre-treatment and post-treatment (6-8 weeks later) for patient; Through study completion (an average of 24 months) for clinicians
2) Evidence-Based Practice Attitudes Scale (EBPAS)
Through study completion, an average of 24 months
3) Workplace Stress Scale (WSS)
Through study completion, an average of 24 months
4) Organizational Readiness for Implementing Change (ORIC)
Through study completion, an average of 24 months
5) Clinicians expertise
Through study completion, an average of 24 months
- +3 more secondary outcomes
Study Arms (1)
Stepped care CBT-I
EXPERIMENTALInterventions
Each week, the patients first have to read written information on the website (www.insomnet.ca), and then watch a video capsule (duration between 5 and 20 min each). Patients complete their daily sleep diary electronically on the website and the content is interactive. It includes the sending of automated emails to remind participants to complete the treatment tasks and encourage adherence, provision of tailored feedback (e.g., texts, charts) based on the information that they provide in their sleep diary, as well as quizzes with automated correction to reinforce patients' understanding of the content.
Patients who obtain an ISI score of 8 and more after completing the web-based CBT-I are "stepped up" and offered to receive up to three 50-min booster sessions of CBT-I offered individually by a psychologist (if needed). Remitted patients (good sleepers; ISI score lower than 8) will receive no further treatment.
Eligibility Criteria
You may qualify if:
- have received a diagnosis of non-metastatic cancer (any type)
- to be aged 18 years and older
- to be readily able to read and understand French or English
- having the minimum cognitive abilities to read, understand and memorize information
- having access to Internet
You may not qualify if:
- having a psychological comorbidity needing clinical attention (e.g., major depressive disorder)
- having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia)
- having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Quebec-Universite Lavallead
- Canadian Institutes of Health Research (CIHR)collaborator
- Canadian Cancer Society (CCS)collaborator
Study Sites (1)
Centre de recherche de L'Hôtel-Dieu de Québec
Québec, G1R 2J6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josée Savard, Ph.D.
Centre de recherche du CHU de Québec-Université Laval
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
March 18, 2021
First Posted
March 26, 2021
Study Start
December 13, 2019
Primary Completion
May 30, 2025
Study Completion
May 30, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share